CSIMarket Company Name, Ticker, Customers, else..
 
Oncosec Medical Incorporated  (NASDAQ: ONCS)
 

ONCS's Market share relative to its competitors, as of Q2 2022

As of Q2 2022 (Revenue in Millions of $)

Date modified: 2026-09-01T06:12:10+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q2 2022		 MARKET SHARE
12 Months
Q2 2022		 MARKET SHARE
MRQ
Q2 2022		 MARKET SHARE
A Quarter Before
Q1 2022
Oncosec Medical Incorporated 0.00 0.00% 0.00 % 0.00 %
Bristol myers Squibb Company 48,482.00 85.14% 83.49% 86.96%
Cyteir Therapeutics Inc 1,545.00 2.71% 0.00% 0.00%
Madrigal Pharmaceuticals Inc 1,132.49 1.99% 2.26% 2.23%
Supernus Pharmaceuticals inc 776.83 1.36% 1.51% 1.47%
Tg Therapeutics Inc 700.35 1.23% 1.75% 1.43%
121 more competitors available

Sign in to see all competitors for Oncosec Medical Incorporated.

Sign In Create Free Account



ONCS's Market share relative to its competitors, as of Q2 2022 within the Major Pharmaceutical Preparations Industry
As of Q2 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2022		 MARKET SHARE
12 Months Ending
Q1 2022		 MARKET SHARE
MRQ
Q2 2022		 MARKET SHARE

Q1 2022
Oncosec Medical Incorporated 0.00% 0.00% 0.00 % 0.00 %
Bristol myers Squibb Company 85.63% 85.17% 84.12% 87.42%
Cyteir Therapeutics Inc 2.73% 3.54% 0.00% 0.00%
Madrigal Pharmaceuticals Inc 2.00% 1.69% 2.28% 2.25%
Supernus Pharmaceuticals inc 1.37% 1.27% 1.52% 1.48%
Tg Therapeutics Inc 1.24% 1.09% 1.76% 1.43%
113 more companies available

Sign in to see all industry competitors for Oncosec Medical Incorporated.

Sign In Create Free Account



ONCS's Market share relative to its competitors, as of Q2 2022 within the Healthcare Sector
As of Q2 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2022		 MARKET SHARE
12 Months Ending
Q1 2022		 MARKET SHARE
MRQ
Q2 2022		 MARKET SHARE

Q1 2022
Oncosec Medical Incorporated 0.00% 0.00% 0.00 % 0.00 %
Bristol myers Squibb Company 85.14% 84.72% 83.49% 86.96%
Cyteir Therapeutics Inc 2.71% 3.53% 0.00% 0.00%
Madrigal Pharmaceuticals Inc 1.99% 1.68% 2.26% 2.23%
Supernus Pharmaceuticals inc 1.36% 1.26% 1.51% 1.47%
Tg Therapeutics Inc 1.23% 1.08% 1.75% 1.43%
121 more companies available

Sign in to see all sector competitors for Oncosec Medical Incorporated.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Oncosec Medical Incorporated's market divisions, geographic dispersion, segments, products, and services, visit Oncosec Medical Incorporated's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.